Our detection of autoantibodies against DFS70/LEDGF in a subset of PCa patients in 2005 led us to examine its expression in human prostate tumors, which revealed for the first time its overexpression in solid tumors [79]. Here, PSIP1 is linked to prostate neoplasm.